A carregar...
Cariprazine Exhibits Anxiolytic and Dopamine D(3) Receptor-Dependent Antidepressant Effects in the Chronic Stress Model
BACKGROUND: Cariprazine, a D(3)-preferring dopamine D(2)/D(3) receptor partial agonist, is a new antipsychotic drug recently approved in the United States for the treatment of schizophrenia and bipolar mania. We recently demonstrated that cariprazine also has significant antianhedonic-like effects i...
Na minha lista:
| Publicado no: | Int J Neuropsychopharmacol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5632312/ https://ncbi.nlm.nih.gov/pubmed/28531264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyx038 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|